Clinical Trial Detail

NCT ID NCT02420652
Title Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Rutgers, The State University of New Jersey
Indications

prostate cancer

Therapies

Metformin

Age Groups: adult

No variant requirements are available.